Agios Pharmaceuticals (AGIO) Free Cash Flow (QoQ) (2012 - 2026)
Agios Pharmaceuticals (AGIO) Free Cash Flow (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,905.61 Bn | 1,905.55 Bn | - |
| 3 | Akari Therapeutics | 1,011.81 Bn | 1,011.81 Bn | - |
| 4 | BeOne Medicines | 467.29 Bn | 462.50 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.89 Bn | 115.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.28 Bn | 61.53 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.93 Bn | 62.93 Bn | - |
| 8 | Argenx Se | 55.90 Bn | 50.72 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.64 Bn | 34.63 Bn | 959.66 Mn |
| 10 | Agios Pharmaceuticals | 2.22 Bn | 1.49 Bn | 19.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.47% |
| Dec 31, 2025 | -10.72% |
| Sep 30, 2025 | -11.34% |
| Jun 30, 2025 | 30.52% |
| Mar 31, 2025 | 16.72% |
| Dec 31, 2024 | -60.01% |
| Sep 30, 2024 | -15.98% |
| Jun 30, 2024 | 27.27% |
| Mar 31, 2024 | -35.92% |
| Dec 31, 2023 | -19.18% |
| Sep 30, 2023 | 7.09% |
| Jun 30, 2023 | 30.58% |
| Mar 31, 2023 | -55.28% |
| Dec 31, 2022 | 19.12% |
| Sep 30, 2022 | -6.54% |
| Jun 30, 2022 | 28.95% |
| Mar 31, 2022 | -13.48% |
| Dec 31, 2021 | 46.36% |
| Sep 30, 2021 | -142.75% |
| Jun 30, 2021 | 25.42% |